lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
247 rows where filing_period = "third_quarter", filing_year = 2008 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 584208 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 88060b61-fcdb-4ca4-aea7-7a2e47d7d4ee | Q3 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2008 | third_quarter | PHA | Monitor legislative developments in health care | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2008-03-23T11:31:28-04:00 | |
| 584531 | RUBICON ADVISORS, LLC 7f1c5857-b976-4b2b-b419-16e623cd0fd8 | 3A | RUBICON ADVISORS, LLC | 315091 | TEVA PHARMACEUTICALS USA | 2008 | third_quarter | PHA | Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 | 105000 | 0 | 0 | 2008-03-31T09:38:35-04:00 | ||
| 659334 | DOW LOHNES GOVERNMENT STRATEGIES LLC 42d0a150-4cc1-44e4-851c-31c62e140239 | 3T | DOW LOHNES GOVERNMENT STRATEGIES LLC | 316013 | APOTEX CORP | 2008 | third_quarter | PHA | H.R. 3700 Fair Medicaid Drug Payment Act of 2007, provisions related to regulation of generic drugs and consumer access; H.R. 1902 Protecting Consumer Access to Generic Drugs Act of 2007, all provisions related to generic drug consumer access; H.R. 3610 Food and Drug Import Safety Act of 2007, provisions related to drug safety. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2008-09-04T17:27:19-04:00 | |
| 659712 | THE PETRIZZO GROUP, INC. 5f70b0c2-c3ef-4c82-a94c-cfdcebe5d7bb | 3A | THE PETRIZZO GROUP, INC. | 305932 | STRATUS PHARMACUETICALS INC | 2008 | third_quarter | PHA | FDA approval of papain products | Food & Drug Administration (FDA) | 10000 | 0 | 0 | 2008-09-26T11:30:52-04:00 | |
| 660108 | MARSHALL BRACHMAN e535d900-2b99-4643-96c0-ece1c0e885c9 | Q3 | MARSHALL BRACHMAN | 6848 | STEWART JACKSON PHARMACAL | 2008 | third_quarter | PHA | Senate HELP Committee and House Energy and Commerce Committee: monitor FDA legislation related to regulation of pharmaceutical manufacturing | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2008-10-01T13:29:14-04:00 | |
| 660269 | CYBER SECURITY RESEARCH CONSULTANTS, LLC 3d152d73-3959-418e-ac1f-b319a116e8fd | Q3 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2008 | third_quarter | PHA | Monitoring Dorgan-Snowe drug reimportation from Canada FY 09 Emergency Supplemental Appropriations | HOUSE OF REPRESENTATIVES | 10000 | 0 | 0 | 2008-10-02T13:57:04-04:00 | |
| 660581 | INDEPENDENT PHARMACY COOPERATIVE 3505f30f-c726-49ab-8f5f-2689d73b3fed | Q3 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2008 | third_quarter | PHA | H.R. 6331 "Medicare Improvements for Patients and Providers Act of 2008" H.R. 5839, Safeguarding Americas Pharmaceuticals Act | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2008-10-03T16:17:41-04:00 | |
| 660790 | STANTON PARK GROUP 94096c80-5621-4e77-b959-a22319b9810b | Q3 | STANTON PARK GROUP | 83717 | MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY) | 2008 | third_quarter | PHA | Drug Safety issues; erythropoiesis stimulating agents (ESAs) safety and use | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2008-10-06T10:53:07-04:00 | |
| 660805 | STANTON PARK GROUP 2c5c2155-c924-4afb-b579-b15c3ddb27a0 | Q3 | STANTON PARK GROUP | 83717 | BARR LABORATORIES | 2008 | third_quarter | PHA | Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-06T11:00:11-04:00 | |
| 660942 | GO DADDY.COM 2c74d2cb-f863-42a6-817d-95e8e78feef4 | Q3 | GO DADDY.COM | 303553 | GO DADDY COM | 2008 | third_quarter | PHA | S. 980 Controlled Substances Act H.R. 6353, The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE | 169500 | 0 | 0 | 2008-10-06T14:23:04-04:00 | |
| 661329 | DUTKO WORLDWIDE, LLC 9557de25-bb99-4462-a362-296c0171ed21 | Q3 | DUTKO WORLDWIDE, LLC | 12868 | IBIS BIOSCIENCES | 2008 | third_quarter | PHA | Counsel and advise client regarding attempts to secure federal procurement contracts for biosensor device. | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2008-10-07T12:55:16-04:00 | |
| 661726 | CARDENAS PARTNERS, LLC 591fcfc4-e2bc-4cd2-818a-6d67c3a3d98f | 3T | CARDENAS PARTNERS, LLC | 284573 | SCHERING CORPORATION | 2008 | third_quarter | PHA | Seeking U.S. Embassy support for American sales of pharmaceuticals in Latin America | Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,State, Dept of (DOS) | 50000 | 0 | 1 | 2008-10-08T13:30:20-04:00 | |
| 661802 | VENABLE LLP 1f28702e-9edc-43c2-9f05-512fde11c821 | Q3 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2008 | third_quarter | PHA | General issues affecting the pharmaceutical industry. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2008-10-08T15:12:00-04:00 | ||
| 661993 | DUTKO WORLDWIDE, LLC e500980b-18c8-4754-8b60-952f3bcb8924 | Q3 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2008 | third_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762 | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-08T17:10:45-04:00 | |
| 662256 | HAMILTON ADVISORS INC. 594ed925-5537-4d3d-af47-7c151855924e | 3A | HAMILTON ADVISORS INC. | 400306434 | SANOFI-AVENTIS | 2008 | third_quarter | PHA | Medicare Never Events | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-09T11:13:57-04:00 | |
| 662489 | VAN FLEET ASSOCIATES 23c63a2d-60c9-4bc5-8c9a-5b66069b89e2 | 3T | VAN FLEET ASSOCIATES | 39781 | KIRK PHARMACEUTICALS | 2008 | third_quarter | PHA | FDA, DEA regulations pertaining to over the counter drug sales. | 0 | 1 | 2008-10-09T14:31:00-04:00 | |||
| 662578 | TIMMONS AND COMPANY, INC. 48daef11-bc2f-49b9-a923-8be1b25d8d91 | Q3 | TIMMONS AND COMPANY, INC. | 38164 | TEVA PHARMACEUTICALS USA INC | 2008 | third_quarter | PHA | S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. S. 1505 - Affordable Biologics for Consumers Act. S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007. S. 251 - Pharmaceutical Market Access Act of 2007. S. 1082 - Prescription Drug User Fee Amendments of 2007. H.R. 2900 - Food and Drug Administration Amendments Act of 2007. H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act. H.R. 1038 - Access to Life-Saving Medicine Act. H.R. 5629 - Pathway for Biosimilars Act H.R. 3610 - Food and Drug Import Safety Act of 2007 H.R. 3624 - Consumer Food Safety Act of 2007 | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2008-10-09T15:16:56-04:00 | |
| 662672 | ANIMAL HEALTH INSTITUTE 00180b38-a5b2-4f42-9717-211f9b718da8 | Q3 | ANIMAL HEALTH INSTITUTE | 4037 | ANIMAL HEALTH INSTITUTE | 2008 | third_quarter | PHA | Animal drug and biologics regulation and approval process; Antibiotic Resistance; Animal Drug User Fee Act; HR 962 & S 549, Preservation of Antibiotics for Medical Treat Act of 2007; HR 2419, Farm, Nutrition, and Bioenergy Act of 2007; S 2302, Food And Energy Security Act of 2007; HR 3697 & S 2313, Strategies to Address Antimicrobial Resistance Act; HR 6432, Animal Drug User Fee Amendments Act of 2008 | Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 35000 | 0 | 0 | 2008-10-09T17:28:23-04:00 | |
| 662677 | WINBORN SOLUTIONS LLC 7b0589a5-b8c1-41a2-a624-f9b48af5a4d4 | Q3 | WINBORN SOLUTIONS LLC | 308310 | PERRIGO CO | 2008 | third_quarter | PHA | Food and drug safety, user fee, and country of origin legislation | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2008-10-09T17:40:27-04:00 | |
| 662979 | MR. JONATHAN BAND bbeb8284-cf3d-49aa-a567-3018018899cd | Q3 | MR. JONATHAN BAND | 297215 | NETCOALITION COM | 2008 | third_quarter | PHA | Online Pharmacies (Section 2(j) of S. 980) | HOUSE OF REPRESENTATIVES,SENATE,U.S. Copyright Office,U.S. Trade Representative (USTR) | 10000 | 0 | 0 | 2008-10-10T14:24:08-04:00 | |
| 663101 | LATHAM & WATKINS LLP 6202bc3e-0b95-4460-a2c2-b6da5ee67be6 | Q3 | LATHAM & WATKINS LLP | 22201 | AMPHASTAR PHARMACEUTICALS | 2008 | third_quarter | PHA | Congressional oversight of the Food and Drug Administration and Environmental Protection Agency EPA rulemaking on CFC propellants | Environmental Protection Agency (EPA),Food & Drug Administration (FDA) | 10000 | 0 | 0 | 2008-10-10T16:30:25-04:00 | |
| 663103 | LATHAM & WATKINS LLP c8bba92f-5725-4cf7-ba80-7b6a76a7f3ce | Q3 | LATHAM & WATKINS LLP | 22201 | ORCHID CHEMICALS & PHARMACEUTICALS LTD | 2008 | third_quarter | PHA | Food and Drug Administration policy. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2008-10-10T16:31:27-04:00 | |
| 663230 | INTERNATIONAL COMMERCE DEVELOPMENT CORP 42093032-0b66-4be6-b00e-1ecf8e219f6c | Q3 | INTERNATIONAL COMMERCE DEVELOPMENT CORP | 286278 | AMPHASTAR PHARMACEUTICALS INC | 2008 | third_quarter | PHA | Seeking generic pharmaceuticals approvals for client from the FDA and EPA. | Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-11T19:44:55-04:00 | |
| 663720 | CROWELL & MORING LLP 803e8571-5a04-4805-a0f0-8429f4ab82b5 | Q3 | CROWELL & MORING LLP | 11377 | THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2008 | third_quarter | PHA | Ensuring adequate and effective intellectual property rights for pharmaceutical products in non-U.S. markets. | U.S. Trade Representative (USTR) | 0 | 0 | 2008-10-13T13:27:58-04:00 | ||
| 663748 | MICHAEL POLLARD 71c11771-6ef6-4dfd-815c-0d08df71824b | Q3 | MICHAEL POLLARD | 87836 | MEDCO HEALTH SOLUTIONS INC | 2008 | third_quarter | PHA | HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all as | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE | 50000 | 0 | 0 | 2008-10-13T14:04:13-04:00 | |
| 663774 | WINSTON & STRAWN LLP 953c8117-df42-435a-9d67-bdc150aef381 | Q3 | WINSTON & STRAWN LLP | 41682 | ABRAXIS BIOSCIENCE LLC | 2008 | third_quarter | PHA | Issues related to safety of breast cancer drugs | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2008-10-13T14:32:26-04:00 | |
| 663795 | WINSTON & STRAWN LLP 66b83779-df85-402a-b177-0d4358de1f69 | Q3 | WINSTON & STRAWN LLP | 41682 | BARR LABORATORIES INC | 2008 | third_quarter | PHA | Hatch - Waxman reform | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2008-10-13T14:47:33-04:00 | |
| 664365 | POLICY ADVOCATES 6f611bb6-c7bb-48d6-a609-c4a9f7a2c176 | Q3 | POLICY ADVOCATES | 72018 | PHOENIX CAPITAL MANAGEMENT LLC | 2008 | third_quarter | PHA | S.980: Online Pharmacy Consumer Protection Act of 2007 - Track and monitor. S.596: Safe Internet Pharmacy Act of 2007 - Track and monitor. S.554: Act For Our Kids - Track and monitor. HR 380: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. S. 242: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. H.R. 6353: Ryan Haight Online Pharmacy Consumer Protection Act of 2008 - Track and monitor. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2008-10-14T10:46:58-04:00 | |
| 664396 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY ddd33819-a9e7-43ef-9ca7-35438d96d4a6 | Q3 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY | 62277 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY | 2008 | third_quarter | PHA | H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicine Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 340000 | 0 | 0 | 2008-10-14T10:56:45-04:00 | |
| 664983 | MR. THEODORE (TED) JONES 61a0427f-ca49-4de1-b56a-5b075106820b | Q3 | MR. THEODORE (TED) JONES | 20926 | PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA | 2008 | third_quarter | PHA | Trade Association for certain Pharmaceutical Companies | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2008-10-14T14:44:19-04:00 | |
| 664999 | M.J. SIMON & COMPANY, LLC f1bb3027-e9db-44ba-8965-ce273f64b68e | Q3 | M.J. SIMON & COMPANY, LLC | 40026223 | BRAIDWOOD MANAGEMENT (FORM JEFFERSON CONSULT GP - HOTZE HEALTH CENTERS) | 2008 | third_quarter | PHA | Pharmacy Compounding | HOUSE OF REPRESENTATIVES,SENATE | 12500 | 0 | 0 | 2008-10-14T14:50:11-04:00 | |
| 665159 | BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 13af961a-d575-4b84-b609-987e08af8b9a | Q3 | BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. | 6382 | BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | 2008 | third_quarter | PHA | E-Prescribing: Effectiveness Research | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 320000 | 0 | 0 | 2008-10-14T15:32:52-04:00 | |
| 665231 | ALCALDE & FAY a97a120c-4c4d-49cc-bde6-e94388a0f3c6 | Q3 | ALCALDE & FAY | 818 | XSTREAM SYSTEMS, INC. | 2008 | third_quarter | PHA | Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA) | 30000 | 0 | 0 | 2008-10-14T15:45:22-04:00 | |
| 665383 | CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS) ef2e9a9b-fdb5-4668-8790-694d0d4aa9e9 | Q3 | CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS) | 5062 | ALCALDE & FAY (XSTREAM SYSTEMS INC ) | 2008 | third_quarter | PHA | Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2008-10-14T16:17:18-04:00 | |
| 665549 | PARRY, ROMANI, DECONCINI & SYMMS 0d91c6de-72bc-4a73-ae80-9b079bd53eac | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | INTL ACADEMY OF COMPOUNDING PHARMACISTS | 2008 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate) | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-14T18:09:09-04:00 | |
| 665565 | BROWNSTEIN HYATT FARBER SCHRECK, LLP b6f80c78-41bc-49c5-85ac-d1a56edca296 | Q3 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | NEUROMOLECULAR PHARMACEUTICALS | 2008 | third_quarter | PHA | Issues relating to pandemic influenza and governmental preparedness | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-14T18:33:33-04:00 | |
| 665612 | MEDCO HEALTH SOLUTIONS, INC 10f3d10c-6d18-4084-a140-28cc77997526 | Q3 | MEDCO HEALTH SOLUTIONS, INC | 89177 | MEDCO HEALTH SOLUTIONS INC | 2008 | third_quarter | PHA | Electronic Prescribing, Rule for Calculating Average Manufacturing Price for Prescription Drugs, Pharmacy Payments, Antitrust Exemption for Independent Pharmacies, Internet Pharmacies, Electronic Prescribing of Controlled Substances HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 434097 | 0 | 0 | 2008-10-14T20:08:17-04:00 | |
| 665974 | M.J. SIMON & COMPANY, LLC d5523ef6-1a0c-444c-bfd4-e3c846af7c66 | Q3 | M.J. SIMON & COMPANY, LLC | 40026223 | WOMEN'S INTERNATIONAL PHARMACY INC (FORM JEFFERSON CONSULT GP - WOMEN'S INT) | 2008 | third_quarter | PHA | Pharmacy Compounding | HOUSE OF REPRESENTATIVES,SENATE | 12500 | 0 | 0 | 2008-10-15T10:52:03-04:00 | |
| 666012 | POLICY DIRECTIONS INC. 7d5c11fc-031c-4372-bf13-04f198c17671 | Q3 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2008 | third_quarter | PHA | Antibiotics in animal foods Drug approvals S. 549/HR 962, all titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. HR 3610 to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2008-10-15T11:06:00-04:00 | |
| 666052 | M.J. SIMON & COMPANY, LLC 8abcc845-4007-414e-abb3-65b7962f1a59 | Q3 | M.J. SIMON & COMPANY, LLC | 40026223 | WOMEN'S INTERNATIONAL PHARMACY INC (FORM JEFFERSON CONSULT GP - WOMEN'S INT) | 2008 | third_quarter | PHA | Pharmacy Compounding | HOUSE OF REPRESENTATIVES,SENATE | 12500 | 0 | 0 | 2008-10-15T11:14:25-04:00 | |
| 666080 | MARC ASSOCIATES, INC. c9462d84-8f53-4ec6-b031-b1ea37e793d1 | Q3 | MARC ASSOCIATES, INC. | 23747 | AMERICAN SOCIETY OF HEMATOLOGY | 2008 | third_quarter | PHA | Oncology drug issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2008-10-15T11:21:16-04:00 | |
| 666166 | BROYDRICK & ASSOCIATES a39f8350-74f0-4a8d-9871-2dce7c8571d1 | Q3 | BROYDRICK & ASSOCIATES | 7268 | BARR LABORATORIES | 2008 | third_quarter | PHA | Patent reform, Generic Biologies | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2008-10-15T11:36:06-04:00 | ||
| 666182 | AMERICAN CAPITOL GROUP 859c4325-4c10-4514-9d38-cf2940e8999e | Q3 | AMERICAN CAPITOL GROUP | 305852 | DISPENSING SOLUTIONS INC | 2008 | third_quarter | PHA | Drug Reimportation, Pharmacy, Counterfiet Drugs, HR 5839, the Safeguarding America's Pharmaceuticals Act | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2008-10-15T11:37:43-04:00 | |
| 666188 | MARC ASSOCIATES, INC. 27aadbc3-2bba-4d61-98d8-e6748099a53c | Q3 | MARC ASSOCIATES, INC. | 23747 | NATIONAL HEMOPHILIA FOUNDATION | 2008 | third_quarter | PHA | Blood and blood product safety. Issue related to blood product approvals. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2008-10-15T11:38:45-04:00 | |
| 666207 | PARRY, ROMANI, DECONCINI & SYMMS 65136d4e-c791-4822-aa6c-4c45970fc7d3 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2008 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate) | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2008-10-15T11:41:27-04:00 | |
| 666286 | KEVIN MCGUINESS PLLC 461ff98a-eafd-4dae-b462-72a3322bba02 | Q3 | KEVIN MCGUINESS PLLC | 299811 | BARR LABS | 2008 | third_quarter | PHA | Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2008-10-15T11:50:14-04:00 | |
| 666352 | UPS (UNITED PARCEL SERVICE) 7fca7d2f-e8d1-4e13-a055-672ef1f88b33 | Q3 | UPS (UNITED PARCEL SERVICE) | 39223 | UPS (UNITED PARCEL SERVICE) | 2008 | third_quarter | PHA | HR 5839 Safeguarding America's Pharmaceuticals Act of 2008 Pedigree - pharmaceutical distribution On-line Pharmacy | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection | 1427517 | 0 | 0 | 2008-10-15T12:03:42-04:00 | |
| 666700 | THE UNITED STATES PHARMACOPEIAL CONVENTION 7cefd9bf-a1c5-450a-ac31-4d7f3c336b6a | Q3 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 400358632 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 2008 | third_quarter | PHA | -NO BILL NUMBER - Review revisions to FDA draft drug safety title, specific interest in the recognition of standards -S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions -S. 3408: Comparative Effectiveness Research Act of 2008, Regarding all provisions -Review draft legislation on medication errors | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2008-10-15T13:39:51-04:00 | |
| 666868 | TIMMONS AND COMPANY, INC. bd448ead-875f-4c19-9a33-71b81cf827bc | Q3 | TIMMONS AND COMPANY, INC. | 38164 | GO DADDY.COM | 2008 | third_quarter | PHA | H.R. 6353 - Ryan Haight Online Pharmacy Consumer Protection Act of 2008 | HOUSE OF REPRESENTATIVES,SENATE | 25000 | 0 | 0 | 2008-10-15T14:22:27-04:00 | |
| 667074 | AMERICAN COLLEGE OF CLINICAL PHARMACY cbe2917b-aee7-4a7b-a08b-b4410a5f09ff | Q3 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2008 | third_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare Part B. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 55950 | 0 | 0 | 2008-10-15T14:55:32-04:00 | |
| 667447 | UNIVERSITY OF CONNECTICUT 142e2981-5f4f-4036-8c4d-0c92fe99bbe0 | Q3 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2008 | third_quarter | PHA | Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues. H.R. 2900, Food and Drug Administration Amendments Act of 2007, Drug safety related issues. S. 3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. | Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA) | 60000 | 0 | 0 | 2008-10-15T16:04:13-04:00 | |
| 667548 | AVENUE SOLUTIONS 2c87a2c3-e9c3-42aa-bfc0-8bc354094e75 | Q3 | AVENUE SOLUTIONS | 72111 | EXPRESS SCRIPTS INC | 2008 | third_quarter | PHA | Issues relating to prompt pay. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2008-10-15T16:18:37-04:00 | |
| 667568 | AVENUE SOLUTIONS a18fac6e-b4bc-40a2-89ed-d8097b79c6ca | Q3 | AVENUE SOLUTIONS | 72111 | UNITEDHEALTH GROUP INC | 2008 | third_quarter | PHA | Issues relating to prompt pay. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2008-10-15T16:21:52-04:00 | |
| 667807 | FOOD MARKETPLACE INC. 079f014f-42bb-46dd-a83f-e1b7d1f61ede | Q3 | FOOD MARKETPLACE INC. | 15097 | FOOD MARKETPLACE INC | 2008 | third_quarter | PHA | HR 6337, Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 - Title III, Privacy and Security Provisions - would require a patient's written consent before using their health information for certain purposes. HR 6331Medicare Patients and Providers Improvement Act - AMP - Provisions relating to retail pharmacy and Medicaid drug reimbursement (became public law 7/15/08) HR 5839, Safeguarding America's Pharmaceuticals Act - E-Pedigree mandates, enhanced wholesaler licensing, national uniform standards HR 970 and S. 2274, Dextromethorphan Distribution Act of 2007- prohibits sale of DXM products to persons under 18 years of age. HR 6898, Health-e Information Technology Act of 2008, Title IV, Privacy and Security Provisions - allows pharmacies to use protected health information for treatment, payment and healthcare operations. | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE | 1600130 | 0 | 0 | 2008-10-15T17:00:36-04:00 | |
| 667870 | OMNICARE, INC. ddbf1a94-6ab9-40b2-a1e0-d816a3260547 | Q3 | OMNICARE, INC. | 321112 | OMNICARE INC | 2008 | third_quarter | PHA | Seeking clarifying information from Drug Enforcement Administration on emergency oral prescription policy | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE | 89642 | 0 | 0 | 2008-10-15T17:23:00-04:00 | |
| 667892 | EXPRESS SCRIPTS, INC. d615c700-f96b-403d-b922-246453c351b2 | Q3 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2008 | third_quarter | PHA | HR 1038/HR 1956/S 1695/HR 5629--creation of a regulatory pathway for generic biologics S 1088/S 28/S 316/HR 1902--Issues related to bringing generics to market in a timely fashion S. 596/S. 980/HR 6353--internet pharmacy regulations HR 5839--issues relating to prescription drug pedigree/drug safety | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE | 240000 | 0 | 0 | 2008-10-15T17:32:11-04:00 | |
| 668107 | AMERICA'S ESSENTIAL HOSPITALS 9ea9dcaa-a5cc-4e5e-ab3b-536bb30dc8c6 | Q3 | AMERICA'S ESSENTIAL HOSPITALS | 27057 | AMERICA'S ESSENTIAL HOSPITALS | 2008 | third_quarter | PHA | H.R. 2606 and S. 1376, 340B Program Improvement and Integrity Act of 2007 | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2008-10-15T19:11:33-04:00 | |
| 668155 | BROWNSTEIN HYATT FARBER SCHRECK, LLP 60cd6d20-2664-4f79-a1af-fe6eca33c37f | Q3 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | JOHNSON & JOHNSON SERVICES, INC. | 2008 | third_quarter | PHA | Follow-on Biologics Judicial Pay Controlled substances Pre-emption; legal reform S.1695-Biologics Price Competition and Innovation Act of 2007 S.1638-Federal Judicial Salary Restoration Act of 2007 H.R.3753-Federal Judicial Salary Restoration Act of 2007 S.1276-Methamphetamine Production Prevention Act of 2007 S.2274-Dextromethorphan Abuse Reduction Act of 2007 S.2450-To amend the Federal Rules of Evidence to address the waiver of the attorney-client privilege and the work product doctrine | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2008-10-15T21:15:30-04:00 | |
| 668194 | BROWNSTEIN HYATT FARBER SCHRECK, LLP 04ea3948-8493-4bc5-b1b2-ba2eae4f457d | Q3 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | SANOFI-AVENTIS US | 2008 | third_quarter | PHA | FDA drug approval process S.1695-Biologics Price Competition and Innovation Act | 90000 | 0 | 0 | 2008-10-15T22:03:54-04:00 | ||
| 668820 | PARRY, ROMANI, DECONCINI & SYMMS 82e71148-88c8-4191-904c-69f9d7e8aa94 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2008 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate) | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2008-10-16T11:05:49-04:00 | |
| 668957 | PARRY, ROMANI, DECONCINI & SYMMS 916b297f-8e1a-4293-825f-c2a7a9bf67d7 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) | 2008 | third_quarter | PHA | No specific legislation or bills introduced at this time. Medicare reimbursement issues. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-16T11:23:25-04:00 | |
| 669079 | GOODWIN PROCTER LLP 4572c897-14c0-4361-bacf-4207c1713aac | Q3 | GOODWIN PROCTER LLP | 79756 | TEVA PHARMACEUTICALS USA INC | 2008 | third_quarter | PHA | S.623 ACCESS TO LIFE SAVING MEDICINES ACT; H.R.1038 ACCESS TO LIFE SAVING MEDICINES ACT; S.1505 AFFORDABLE BIOLOGICS FOR CONSUMERS; S.1695 BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; H.R. 1956 THE PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINE ACT (ALL PROVISIONS FOR ALL BILLS) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2008-10-16T11:36:53-04:00 | |
| 669233 | FABIANI & COMPANY 10ec177c-d2b0-48c5-9b79-065e382b805e | Q3 | FABIANI & COMPANY | 72576 | ALNYLAM PHARMACEUTICALS | 2008 | third_quarter | PHA | S.1145 Patent Reform Act Provisions relating to the apportionment of damages | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2008-10-16T12:00:09-04:00 | |
| 669489 | SQUIRE PATTON BOGGS d39b5924-d390-4260-94a6-1e1ab4977fc0 | Q3 | SQUIRE PATTON BOGGS | 30906 | KERR CORPORATION | 2008 | third_quarter | PHA | FDA enforcement action against counterfeits of client's medical devices. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES | 10000 | 0 | 0 | 2008-10-16T12:50:07-04:00 | |
| 669721 | SQUIRE PATTON BOGGS e9e3478f-6a66-4c3b-96a4-5f515d43b36f | Q3 | SQUIRE PATTON BOGGS | 30906 | SUNOVION PHARMACEUTICALS INC | 2008 | third_quarter | PHA | Issues related to inhalation drugs, including Xopenex. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-16T13:25:35-04:00 | |
| 670162 | FABIANI & COMPANY 8674e84b-4567-4cb9-b70b-bc9da3c3ea03 | Q3 | FABIANI & COMPANY | 72576 | VAXINNATE | 2008 | third_quarter | PHA | Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-16T14:22:24-04:00 | |
| 670405 | FABIANI & COMPANY 1c2ffef2-eddc-4d21-b6e7-c57fc278af64 | Q3 | FABIANI & COMPANY | 72576 | ACORDA THERAPEUTICS, INC. | 2008 | third_quarter | PHA | Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-16T14:46:40-04:00 | |
| 670649 | APOTEX CORP. d19044e0-3fdf-4a9f-bef6-39ec3fa46b66 | Q3 | APOTEX CORP. | 310973 | APOTEX CORP. | 2008 | third_quarter | PHA | S. 316, the Preserve Access to Affordable Pharmaceuticals Act HR 1902, the Protecting Consumer Access to Generic Drugs Act HR 1038, the Access to Life Savings Medicine Act HR 5629, the Pathway for Biosimilars Act S. 1695, the Biologics Price Competition and Innovation Act HR 5829, the Safeguarding America's Pharmaceuticals Act HR 3610, the Food and Drug Import Safety Act, Section 4 User Fees Regarding Drug Safety PL 110-85, the Foord and Drug Amendments Act of 2007, Section 914, Citizen Petition and petition for stay of agency action PL 110-85, the Food and Drug Amendments Act of 2007. Title VIII, Clinical Trial Databases HR 6432, Animal Drug User Fee Amendments of 2008, Section 301, Consideration of Certain Petitions Combating anti-generic substitution legislation in the states Abbreviated New Drug Application No. 76-396 for calcitonin salmon nasal spray | HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2008-10-16T15:11:14-04:00 | |
| 671124 | UNIVERSITY OF PITTSBURGH MEDICAL CENTER fc29dd4b-8968-41f2-acbf-59acc8eab165 | Q3 | UNIVERSITY OF PITTSBURGH MEDICAL CENTER | 32065 | UNIVERSITY OF PITTSBURGH MEDICAL CENTER | 2008 | third_quarter | PHA | Issues related to the cost of prescription pharmaceuticals and the impact of that cost on hospitals and health care providers. | Air Force, Dept of,Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 270000 | 0 | 0 | 2008-10-16T16:05:00-04:00 | |
| 671265 | NOVO NORDISK INC. cbbffa60-d002-4fb2-a72a-b68b1255c9b3 | Q3 | NOVO NORDISK INC. | 284790 | NOVO NORDISK INC. | 2008 | third_quarter | PHA | H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE | 300000 | 0 | 0 | 2008-10-16T16:24:39-04:00 | |
| 671853 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) 0f04a3b5-cf28-4cbd-8c76-6cc4776d7880 | Q3 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) | 9237 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) | 2008 | third_quarter | PHA | S.1505, Affordable Biologics for Consumers Act, issues relating to long term safety and effectiveness of medical devices and drugs. | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 341435 | 0 | 0 | 2008-10-16T18:05:27-04:00 | |
| 671996 | VAN SCOYOC ASSOCIATES 4f05bf35-bfe4-4d19-872e-85364ffca86a | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF CONNECTICUT | 2008 | third_quarter | PHA | Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues. H.R.2900, Food and Drug Administration Amendemtns Act of 2007, Drug safety related issues. S.3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. | Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA) | 50000 | 0 | 0 | 2008-10-16T18:49:14-04:00 | |
| 672012 | VAN SCOYOC ASSOCIATES 68bba4da-ad4d-454e-a65e-da43d0a47884 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF MARYLAND BALTIMORE | 2008 | third_quarter | PHA | Implementation of Prescription Drug User Fee Amendments, 2007 (PL 110-85), Drug safety related issues. H.R. 2900, Food and Drug Administration Amendments Act of 2007, drug safety related issues. S.3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. | Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-16T18:54:19-04:00 | |
| 672019 | VAN SCOYOC ASSOCIATES 783784ae-3503-4183-8c9b-ec85f33020d8 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE | 2008 | third_quarter | PHA | S.3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA and USDA funding initiatives. Implementation of Prescription Drug User Fee Amendments, 2007 (Public Law 110-85), Drug safety related issues. H.R. 3580, Food and Drug Administration Amendments Act of 2007, Drug safety and science related issues. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2008-10-16T18:56:21-04:00 | |
| 672429 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES 61958dd1-55fd-4ccf-b5a8-699d0c2c1c2d | Q3 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2008 | third_quarter | PHA | See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity for healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology. H.R. 6491/S.3434, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 6713, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R. 6831/S.3666, the Copper Theft Prevention Act of 2008 as related to theft and interstate fencing of stolen copper. H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technolo… | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Natl Drug Control Policy (NDCP),President of the U.S.,SENATE | 300000 | 0 | 0 | 2008-10-17T09:39:46-04:00 | |
| 672446 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 86323c24-1f83-4808-98cb-b271aa77da4e | Q3 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2008 | third_quarter | PHA | Importation of prescription drugs (H.R. 3161) (S. 1644) (S. 3409) Rx Pedigree (H.R. 5839) Methamphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) (H.R. 6353) | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 140673 | 0 | 0 | 2008-10-17T09:44:25-04:00 | |
| 672781 | VORYS, SATER, SEYMOUR AND PEASE LLP 06f1896c-d966-4272-aa78-d157afe1da76 | Q3 | VORYS, SATER, SEYMOUR AND PEASE LLP | 40236 | SOLVAY PHARMACEUTICALS INC | 2008 | third_quarter | PHA | Implementation of national strategy to prepare for pandemic influenza. FY 2009 Labor, HHS appropriations bill S.3230 | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2008-10-17T10:35:19-04:00 | |
| 672921 | POLICY IMPACT COMMUNICATIONS, INC. 608efcb2-1a45-4d3a-b97d-0716325d0f69 | Q3 | POLICY IMPACT COMMUNICATIONS, INC. | 31758 | STRATEGIC APPLICATIONS INTERNATIONAL LLC | 2008 | third_quarter | PHA | Development of legislation to restore Medicaid benefits for mentally ill offenders. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2008-10-17T10:45:31-04:00 | |
| 673148 | AARP 1d46f2c3-9c8b-4b3b-b4a6-c1a92cd4cee8 | Q3 | AARP | 1694 | AARP | 2008 | third_quarter | PHA | S 623/HR 1038 (Access to Life Saving Medicine Act), HR 1956 (Patient Protection and Innovative Biologic Medicines Act of 2007), HR 5629 (Pathway for Biosimilars Act) - Lobbied to ensure that Waxman Biogenerics legislation is enacted particularly provisions related to ensuring a safe, effective pathway for the approval of comparable, interchangeable biologics. HR 1902 (Protecting Consumer Access to Generic Drugs Act of 2007)/ S 316 (Preserve Access to Affordable Generics Act -Provisions related to preventing abuses in patent settlements between generic and brand name prescription drug manufactures. S 1145 Patient Reform Act of 2007- Ensuring that the existing inequitable conduct provisions in Patent Law Act are not weakened. Discussion regarding prescription drug affordability (no Bill). S 3230 Labor/HHS/Education Appropriations FY 2009 - Lobbying for spending levels for Rx comparative effectiveness. S 3289 Agriculture and Rural Development Appropriations, FY 2009 - Lobbied to reduce FDA generic drug processing backlog. | Administration on Aging,Commerce, Dept of (DOC),Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Reserve System,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Social Security Administration (SSA),Treasury, Dept of,White House Office | 7330000 | 0 | 0 | 2008-10-17T10:59:33-04:00 | |
| 673318 | CAPITOL HILL CONSULTING GROUP e2623d57-bfb4-44be-9c39-8631b3511694 | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | DFB PHARMACEUTICALS INC | 2008 | third_quarter | PHA | General Pharmaceutical Issues pertaining to the company. No specific legislation. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-17T11:16:14-04:00 | |
| 673494 | INDEPENDENCE BLUE CROSS 6eee542b-10cd-4014-a713-9e802b2fbb77 | Q3 | INDEPENDENCE BLUE CROSS | 19172 | INDEPENDENCE BLUE CROSS | 2008 | third_quarter | PHA | E-prescribing: Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; "Enhanced Health Care Value of All Act" | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2008-10-17T11:27:12-04:00 | ||
| 673839 | RASKY PARTNERS, INC. 5702c24e-e0fa-44d6-8853-07cdaac0664d | Q3 | RASKY PARTNERS, INC. | 297410 | ELI LILLY AND CO | 2008 | third_quarter | PHA | HR 5629, Pathway for Biosimilars Act Legislation | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-17T11:57:03-04:00 | |
| 673896 | 340B HEALTH 02994312-0148-47bc-92a3-ac97677edfb3 | Q3 | 340B HEALTH | 316434 | 340B HEALTH | 2008 | third_quarter | PHA | HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs | Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 161917 | 0 | 0 | 2008-10-17T12:00:43-04:00 | |
| 673957 | STUNTZ DAVIS & STAFFIER, P.C. aa0e6b73-ec09-4b22-8454-ee28d90891f1 | Q3 | STUNTZ DAVIS & STAFFIER, P.C. | 37141 | ASTRAZENECA PHARMACEUTICALS LP | 2008 | third_quarter | PHA | Drug importation: FDA foreign drug inspection program; Medicaid drug rebates; direct to consumer advertising of pharmaceuticals. | 20000 | 0 | 0 | 2008-10-17T12:07:07-04:00 | ||
| 673978 | CAPITOL HILL CONSULTING GROUP f3da6d95-4e34-436f-9685-de74c3596233 | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2008 | third_quarter | PHA | Controlled Drug Substances Act (21 USC 13) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2008-10-17T12:08:53-04:00 | |
| 674200 | STUNTZ DAVIS & STAFFIER, P.C. f1c692dc-5b60-4bc8-9601-19f4894855ba | Q3 | STUNTZ DAVIS & STAFFIER, P.C. | 37141 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2008 | third_quarter | PHA | Drug safety issues. Pharmaceutical user fees. Foreign drug inspections. Drug reimportation. Direct to consumer drug advertising. | 10000 | 0 | 0 | 2008-10-17T12:30:21-04:00 | ||
| 674550 | THE FRITTS GROUP d84a65ee-2f49-4959-a2c4-93d900de0841 | Q3 | THE FRITTS GROUP | 309275 | CBS | 2008 | third_quarter | PHA | H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007 | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2008-10-17T13:06:08-04:00 | |
| 674569 | THE FRITTS GROUP 53e100ce-073c-4277-a019-6d422b51aece | Q3 | THE FRITTS GROUP | 309275 | NEWS CORPORATION | 2008 | third_quarter | PHA | H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007 | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2008-10-17T13:08:16-04:00 | |
| 674851 | MCDERMOTT WILL & SCHULTE LLP e3b6f706-6120-40f8-b7c8-15b3b8c33864 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2008 | third_quarter | PHA | Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2008-10-17T13:40:12-04:00 | |
| 675034 | DUANE MORRIS GOVERNMENT AFFAIRS f5dd6c1f-eb6f-473a-8bf9-619bbf24119c | Q3 | DUANE MORRIS GOVERNMENT AFFAIRS | 49657 | LEHIGH VALLEY TECHNOLOGIES | 2008 | third_quarter | PHA | Monitor Federal activity relating to pharmaceutical manufacturing. | Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2008-10-17T13:53:56-04:00 | ||
| 675134 | DUANE MORRIS GOVERNMENT AFFAIRS 2ac1b5b3-4a4e-455d-91a3-f12f6df6686f | Q3 | DUANE MORRIS GOVERNMENT AFFAIRS | 49657 | CB DISTRIBUTORS INC | 2008 | third_quarter | PHA | Regulation of over-the-counter asthma-cough medicines. | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-10-17T14:07:40-04:00 | |
| 675404 | BUCHANAN INGERSOLL & ROONEY PC d4f07a04-2965-4fb4-8f54-cc24f79a8f78 | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | XOMA | 2008 | third_quarter | PHA | Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate. | Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 60000 | 0 | 0 | 2008-10-17T14:28:19-04:00 | |
| 675511 | VAN NESS FELDMAN, LLP ad199697-cdfe-42e0-b71e-3d9a0e4368a1 | Q3 | VAN NESS FELDMAN, LLP | 39815 | MCKESSON CORPORATION | 2008 | third_quarter | PHA | S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008 | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-17T14:38:32-04:00 | |
| 675554 | HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY 168f8193-f8ab-4bb8-994d-c42c3e86e380 | Q3 | HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY | 72793 | HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY | 2008 | third_quarter | PHA | E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act" | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2008-10-17T14:44:46-04:00 | |
| 675784 | TARPLIN, DOWNS & YOUNG, LLC c213935f-6a84-4b54-8a34-52b9993146ac | Q3 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2008 | third_quarter | PHA | **see addendum page Importation of prescription drugs (H.R. 3161) (S. 1644) Rx Pedigree (H.R. 5839) Methamphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) (H.R. 6353) | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2008-10-17T15:04:41-04:00 | |
| 675824 | HANCE SCARBOROUGH 4968be84-9e09-47c1-ad96-07061dccf149 | Q3 | HANCE SCARBOROUGH | 17443 | ALLIANCE FOR PHARMACY COMPOUNDING | 2008 | third_quarter | PHA | Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2008-10-17T15:06:52-04:00 | |
| 675955 | BROWN RUDNICK LLP fbb674b9-fd54-4b65-835d-69bb28249baf | Q3 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2008 | third_quarter | PHA | H.R. 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-17T15:13:21-04:00 | |
| 676106 | MENTAL HEALTH AMERICA a1385398-a284-412a-aa10-e0617edf6bbe | Q3 | MENTAL HEALTH AMERICA | 28195 | MENTAL HEALTH AMERICA | 2008 | third_quarter | PHA | Medicare Part D; Comparative effectiveness research legislation | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 24869 | 0 | 0 | 2008-10-17T15:23:51-04:00 | |
| 676151 | WALGREEN COMPANY 2715fcfa-f1cc-4f73-b6ae-7d6ad7885667 | Q3 | WALGREEN COMPANY | 309071 | WALGREEN COMPANY | 2008 | third_quarter | PHA | S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - T… | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 320000 | 0 | 0 | 2008-10-17T15:26:05-04:00 | |
| 676209 | BLUE CROSS AND BLUE SHIELD ASSOCIATION ab07bcf0-f1eb-4db8-a6b6-ba6c5cf5d6e4 | Q3 | BLUE CROSS AND BLUE SHIELD ASSOCIATION | 6358 | BLUE CROSS AND BLUE SHIELD ASSOCIATION | 2008 | third_quarter | PHA | E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act" | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 1800000 | 0 | 0 | 2008-10-17T15:31:26-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);